The Knee Injury and Osteoarthritis Outcome Score (KOOS) is one of the most used Patient-Reported Outcome Measures (PROMs) assessing pain, function and quality of life in people suffering from knee injury and osteoarthritis.
During this webinar, the developer Professor Ewa Roos will give an overview of KOOS with focus on interpretability and use in clinical studies:
- Learn about the KOOS development and the gap it filled. See how attitudes towards PROMs have changed, and reflect on the pros and cons of current outcome assessment methods
- The KOOS 5-subscale structure is demystified. You will receive advice on how to optimize the use of KOOS and how to avoid multiplicity in a trial context
- What level of problems does a KOOS subscale score of 78 represent? Insights include scoring direction, categorization, minimal important difference, patient acceptable symptom state, and treatment failure for clinical interpretation of KOOS scores
- Discover the alternatives to the original KOOS: KOOS-12 and KOOS-Child
After administering and making the KOOS freely available for more than 20 years via a personal website, Professor Roos chose to partner with Mapi Research Trust, as of May 2023, for the distribution and licensing of the KOOS. The speakers will detail the practical conditions of access to the KOOS and share information on the available translations. The KOOS is free to use for non-funded and funded academic users. Commercial users and health care organizations must pay a fee. In both cases, authorization for use is always required.
Speakers
Professor Ewa Roos, Center for Muscle and Joint Health, University of Southern Denmark
Professor Ewa Roos is passionate about advancing the frontiers of knowledge in muscle and joint health. Her focus is on patient-reported outcomes, exercise therapy, surgical treatments and clinical care pathways.
Professor Roos is an internationally leading Researcher and change agent in the field of musculoskeletal health. She is the Author of 300+ peer-reviewed publications, including ground-breaking randomized trials comparing exercise therapy to orthopedic surgery published in high-impact journals, such as the New England Journal of Medicine and the British Medical Journal. Her work is cited 26.000+ times and her H-index is 74.
She has been able to produce high-impact methodological and clinical research and translate that research into patient-reported outcome measures (PROMs) including the KOOS, HOOS and FAOS and clinical tools such as Good Life with Osteoarthritis in Denmark (GLA:D®) available in 10 countries where more than 100,000 patients have received evidence-based osteoarthritis care.
Message Presenter
Katie Flynn, Account Manager, Mapi Research Trust
Katie Flynn has over 10 years of experience in account management and international business development in multi-channel sales, where she gained extensive client services experience. In 2023, Katie joined the Author Collaboration Unit at Mapi Research Trust to establish new collaborations with the Authors and/or copyright holders of clinical outcome assessments (COAs) and assist them with the daily management of their questionnaires.
Message PresenterWho Should Attend?
This webinar will appeal to all practitioners and clinical researchers specializing in knee injuries and osteoarthritis, including:
- Orthopedic Surgeons
- Rheumatologists
- Physical Therapists
- Medical experts, Clinical Research Coordinators, Project Managers and Clinical Trial Managers from pharmaceutical, biotech and medical device companies
What You Will Learn
Attendees will gain insights into:
- KOOS development and the gap it filled
- How to optimize the use of KOOS and how to avoid multiplicity in a trial context
- Scoring direction, categorization, minimal important difference, patient acceptable symptom state and treatment failure for clinical interpretation of KOOS scores
- Alternatives to the original KOOS: KOOS-12 and KOOS-Child
- The KOOS’ conditions of access and available translations
Xtalks Partner
Mapi Research Trust
Mapi Research Trust is a non-profit organization that facilitates access to Clinical Outcome Assessments (COAs) for the entire scientific community. With more than 30 years of experience in the field of COAs and with the online platform ePROVIDE™, which includes databases on COAs (PROQOLID™), claims (PROLABELS™) and guidance (PROINSIGHT™), Mapi Research Trust is the pre-eminent source of information on COAs.
Exclusive distributor of over 700 COAs, Mapi Research Trust is the most trusted name in the distribution of COA instruments.
Related Webinars
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account